Cassier, P. A., Laethem, J. V., Borbath, I., Macarulla, T., Geboes, K. P., Lambert, A., Prenen, H., Mitry, E., Blanc, J., Feliu, J., Cid, R. A. P., Jiménez, I. G., Smith, K. E., Nordbladh, K., Coaña, Y. P. D., O'Reilly, E. M., Jimenez, D. G., Ambarkhane, S. V., Ellmark, P., Beatty, G. L. (2025). Biomarkers associated with outcomes from OPTIMIZE-1: CD40 agonist mitazalimab with mFOLFIRINOX in patients with untreated metastatic pancreatic cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2624